Related Experiment Video

Updated: Jul 4, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Hemostatic effects of bortezomib treatment in patients with relapsed or refractory multiple myeloma

Maurizio Zangari, Jose Guerrero, Federica Cavallo

    Haematologica
    |June 3, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
    09:27

    Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

    Published on: October 10, 2025

    Related Experiment Videos

    Last Updated: Jul 4, 2026

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
    09:41

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

    Published on: July 15, 2015

    Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons
    09:27

    Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

    Published on: October 10, 2025

    Related Concept Videos

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    STING-mediated tumor microenvironment remodeling: turning adaptive resistance into therapeutic vulnerability.

    Frontiers in immunology·2026

    Integrating new and "old" cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma.

    Frontiers in oncology·2026

    Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies.

    Haematologica·2026

    Targeting CDK4/6 in Combination with Phage-Based Anti-HER2 Vaccination Overcomes Immune Evasion and Enhances the Anticancer Response in Breast Cancer.

    Pharmaceutics·2026

    Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

    Blood advances·2026

    Health-related quality of life after acute myocardial infarction and one-year clinical outcomes: A prospective cohort study.

    International journal of cardiology. Cardiovascular risk and prevention·2026

    Autoimmune and inflammatory diseases associated with T-cell clonal expansion.

    Haematologica·2026

    Macrophage-specific LAMTOR2 deletion disrupts systemic iron homeostasis in mice.

    Haematologica·2026

    Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpression.

    Haematologica·2026

    Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trial.

    Haematologica·2026

    Preserving anthracycline-containing treatment in older patients with classical Hodgkin lymphoma: a role for liposomal doxorubicin. Comment on: "Age, anthracycline and mortality in 28,000 classic Hodgkin lymphoma patients: cohort study of a complete population".

    Haematologica·2026

    Mesenchymal stem cells in ribosomal insufficiency lead to aberrant osteoblastic differentiation and altered hematopoiesis.

    Haematologica·2026

    Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.

    International journal of cell biology·2026

    Cuproptosis-related molecular alterations in a neonatal rat model of hypoxic-ischemic brain damage.

    Frontiers in neurology·2026

    Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

    Research square·2026

    A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors.

    bioRxiv : the preprint server for biology·2026

    Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

    Research square·2026

    Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.

    Research square·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us